Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
  1. Homepage
  2. Equities
  3. France
  4. Euronext Paris
  5. Sanofi
  6. Company
    SAN   FR0000120578

SANOFI

(SAN)
  Report
Real-time Euronext Paris  -  11:35:43 2023-06-08 am EDT
95.44 EUR   +0.52%
05:20pPress Release : FDA Advisory Committee unanimously recommends nirsevimab as first immunization against RSV disease for all infants
GL
04:38pADRs End Higher, Innate Pharma and Medigus Trade Actively
DJ
04:21pUS FDA panel backs Sanofi-AstraZeneca's preventive RSV therapy
RE
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisionsFunds 
Business Summary
Logo Sanofi
Sanofi is the largest European pharmaceutical group. Net sales by family of products break down as follows:

- pharmaceutical products (71.4%): prescription drugs in the areas of specialty medicine (54.7% of net sales; for the treatment of multiple sclerosis, neurological diseases, inflammatory diseases, autoimmune diseases, rare diseases, cancers and rare hematological diseases) and general medicine (45.3%; mainly for the treatment of diabetes and cardiovascular diseases);

- human vaccines (16.8%): pediatric vaccines, vaccines for flu, meningitis, and polio, booster vaccines, and vaccines for travelers and endemic areas;

- consumer health products (11.8%).

At the end of 2022, the group had 59 production sites throughout the world.

Net sales are distributed geographically as follows: France (5.3%), Europe (18%), the United States (42.5%), China (7.3%), Japan (3.8%), Brazil (2.1%), Russia (1.5%) and other (19.5%).

Number of employees : 91 573 people.
Sales per Business
20212022Delta
Pharmaceuticals26 970.0071.4%30 688.0071.4% +13.79%
Vaccines6 323.0016.7%7 229.0016.8% +14.33%
Consumer Healthcare4 468.0011.8%5 080.0011.8% +13.7%
EUR in Million
Sales per region
20212022Delta
United States14 385.0038.1%18 275.0042.5% +27.04%
Rest of the World7 850.0020.8%8 386.0019.5% +6.83%
Europe7 503.0019.9%7 703.0017.9% +2.67%
China2 720.007.2%3 123.007.3% +14.82%
France2 256.006%2 296.005.3% +1.77%
Japan1 657.004.4%1 613.003.8% -2.66%
Brazil815.002.2%927.002.2% +13.74%
Russia575.001.5%674.001.6% +17.22%
EUR in Million
Managers
Name Title Age Since
Paul Hudson Chief Executive Officer & Director 55 2019
Jean-Baptiste Chasseloup de Chatillon Chief Financial Officer & Executive Vice President 58 2018
Nestle Frank Global Head-Immunology Therapeutic Research Area - 2016
Dietmar Berger Chief Medical Officer & Global Head-Development - 2019
Eva Schäfer-Jansen Head-Investor Relations - -
Olivier Antoine M. Charmeil Executive Vice President-General Medicines 58 -
Julie van Ongevalle Executive VP & Head-Consumer Healthcare - 2020
William J. Sibold EVP-Specialty Care & President-North America - -
Alexandra Roger Head-Securities Law & Capital Markets - -
Brendan OCallaghan Executive Vice President & Head-Industrial Affairs - 2021
Members of the board
Name Title Age Since
Frédéric Oudéa Chairman 59 2023
Fabienne Lecorvaisier Independent Director 60 2013
Patrick Kron Independent Director 69 2014
Diane D. Souza Independent Director 70 2016
Thomas C. Südhof, Dr. Independent Director 67 2016
Rachel Duan Independent Non-Executive Director 51 2020
Lise Kingo Independent Director 61 2020
Gilles Schnepp Independent Director 63 2020
Barbara Lavernos Independent Director 54 2021
Carole Ferrand Independent Director 52 2022
Equities
Vote QuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 1,260,835,732 1,112,376,732 88.2% 8,195,266 0.6% 88.2%
Shareholders
NameEquities%
L'Oréal S.A. 118,227,307 9.38%
The Vanguard Group, Inc. 31,421,415 2.49%
Norges Bank Investment Management 26,897,859 2.13%
Plan d'Epargne Entreprise Sanofi Synthelabo 25,384,441 2.01%
Dodge & Cox 24,996,804 1.98%
Amundi Asset Management SA (Investment Management) 21,269,779 1.69%
BlackRock Advisors (UK) Ltd. 12,592,350 1.00%
Sanofi 12,195,470 0.97%
FIL Investment Advisors (UK) Ltd. 12,066,299 0.96%
Fidelity Management & Research Co. LLC 10,222,416 0.81%
Holdings
NameEquities%Valuation
SANOFI (SAN) 12,195,470 0.97% 1,346,379,888 USD
SANOFI INDIA LIMITED (500674) 13,909,587 60.4% 947,107,117 USD
EUROAPI (EAPI) 28,298,074 29.9% 340,371,498 USD
ICOSAVAX, INC. (ICVX) 3,155,169 7.62% 17,384,981 USD
SANOFI-AVENTIS PAKISTAN LIMITED (SAPL) 5,099,469 52.9% 12,584,164 USD
CLOUDR GROUP LIMITED (9955) 3,860,600 0.66% 4,760,660 USD
LAVA THERAPEUTICS N.V. (LVTX) 1,919,455 7.30% 2,898,377 USD
Markets and indexes
- PEA / SRD eligible : YES / YES
- Compartiment A
- CAC 40 / CAC 40 ESG, CAC All Shares, CAC All-Tradable, CAC Large 60, Euronext 100, Euronext Equileap Gender Equality Eurozone 100, Euronext Equileap Gender Equality France 40, Euro Stoxx 50, FTSE Eurotop 100, Low Carbon 100 Europe, PEA, SBF 120, Stoxx Europe 50, S
Stock Exchange Codes
- Bloomberg Code :  SAN:FP
- Reuters Code :  SASY.PA
- Datastream Code :  
Company contact information
Sanofi
46 Avenue de la Grande Armée
FR-75017 Paris

Phone : +33 (0)1 53 77 40 00
Fax : +33 (0)1 53 77 44 63
web site : https://www.sanofi.com
Brand Portfolio
In partnership withAllbrands.markets
More brands of Sanofi
Sector Other Pharmaceuticals
1st jan.Capi. (M$)
SANOFI6.23%126 946
JOHNSON & JOHNSON-10.46%443 455
ELI LILLY AND COMPANY19.28%414 234
NOVO NORDISK A/S16.42%351 939
MERCK & CO., INC.-2.11%275 591
ROCHE HOLDING AG-0.91%256 071
ABBVIE INC.-15.54%240 826
ASTRAZENECA PLC4.78%226 935
PFIZER, INC.-24.10%219 546
NOVARTIS AG7.07%206 716
BRISTOL-MYERS SQUIBB COMPANY-8.99%136 891
AMGEN INC.-15.77%118 220
GILEAD SCIENCES, INC.-11.24%94 899
GSK PLC-4.27%69 471
DAIICHI SANKYO CO., LTD.12.26%65 403
BAYER AG7.87%54 827
TAKEDA PHARMACEUTICAL COMPANY LIMITED9.83%50 182
CHUGAI PHARMACEUTICAL CO., LTD17.90%46 708
JIANGSU HENGRUI MEDICINE CO., LTD.18.32%40 721
HALEON PLC-0.35%37 525
ASTELLAS PHARMA INC.12.63%29 033
1 MarketScreener is worth more than 1000 Influencers!
100% Free Registration
fermer